Numinus Offering Ketamine Assisted Psychotherapy At Two Clinics in Canada, Psychedelic Neurology Centre On The Horizon Oct 8, 2021
Mydecine Patent Filing Links Psychedelic Therapeutics & PTSD: Psychedelic Stock Investing Oct 7, 2021
Esports Betting Company Rivalry Makes Stock Market Debut: What The TSX Exchange IPO Means For The Brand Oct 7, 2021
Tryp Therapeutics Announces Collaboration with Researchers at the University of Wisconsin-Madison Oct 7, 2021
MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary – MYND Diagnostics Ltd. Oct 7, 2021
BevCanna Signs White-Label Agreement to Produce Cannabis-Infused Beverages for Xebra Brands Oct 7, 2021
PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment of Parkinson’s Disease Oct 6, 2021
